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were positive for HCoV 229E and 
infl uenza A virus.
In this study, we simultaneously 
analyzed tissue specimens of paranasal 
sinuses and nasal polyps, as well as 
nasal swabs and blood samples, for 
a broad panel of viruses and atypical 
bacteria. To avoid seasonal bias, 
specimens were collected over a 1-year 
period and exclusively obtained from 
patients undergoing elective surgery 
in the absence of acute respiratory 
symptoms.
The fi nding that HBoV was 
present as a single virus in 18/22 virus-
positive biopsy samples is intriguing. 
Moreover, the fact that no HBoV DNA 
was detected in nasal swabs or EDTA-
blood samples indicates no active 
HBoV infection. In previous studies, 
HBoV DNA was frequently identifi ed 
in the adenoids and tonsils of children 
(2,5,10). However, in contrast with 
our fi ndings, detection of HBoV was 
mostly associated with other viruses, 
suggesting that co-virus–induced 
cellular damage might contribute 
to bocavirus reactivation and 
replication (5). Our fi ndings indicate 
that persistence of viral nucleic acid 
in sinus mucosa might be a special 
advantage of HBoV, although the 
relevance of this observation remains 
unclear. Whether this presence as 
a single virus means a dead end 
for HBoV infection, true latency 
including the potential of reactivation, 
or a role in the pathogenesis of clinical 
conditions requiring surgery warrants 
future studies. 
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Hepatitis C Virus, 
Pakistan
To the Editor: The prevalence of 
hepatitis C virus (HCV) infection is 
high (8% of the population) in Pakistan 
(1). HCV is an RNA virus that has a 
high mutation rate. This high rate results 
in extensive genetic heterogeneity, 
and HCV isolates are found as either 
quasispecies or genotypes (2). Humans 
can be co-infected with >1 genotype 
(mixed genotype infection) of this 
virus (3). The rate of HCV mixed 
genotype infections is extremely 
variable for different regions and for 
the same group of patients tested by 
using different assays (4). Thus, it is 
diffi cult to determine the prevalence of 
mixed genotype infections by currently 
available assays, including direct DNA 
sequencing, because they are designed 
to identify only the HCV genotype 
dominant in that particular population. 
Consequently, genotypes present at 
lower frequencies could be missed or 
mistyped (5).
To determine the prevalence of 
HCV mixed genotype infections, we 
retrospectively analyzed genotyping 
data for paired serum samples from 
22,125 HCV-infected patients during 
the past 11 years (March 2000–May 
2010) for all regions in Pakistan by 
using molecular-based genotype-
specifi c methods (6,7). A total of 
12,036 (54.4%) were male patients 
and 10,089 (45.6%) were female 
patients.
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The sensitivity and reliability of 
the assay we used has been assessed 
and found to be superior to restriction 
fragment length polymorphism 
analysis and serotyping methods for 
detection of mixed genotypes in a viral 
population. Our method can detect a 
small amount (8.3%) of HCV RNA 
in a mixed genotype population (7). 
Restriction fragment polymorphism 
analysis can detect 2 genotypes only 
if 1 of them represents >41.6% of 
the genotypes in a mixed genotype 
population.
Of 22,125 HCV RNA-positive 
serum samples, type-specifi c PCR 
bands were observed in 18,181 
(82.2%) samples and 3,944 (17.8%) 
were not typeable. A total of 1,007 
(5.5%) patients had HCV mixed 
genotype infections.
The distribution of mixed genotype 
infections in 1,007 patients is shown in 
the online Appendix Figure (www.cdc.
gov/EID/content/17/8/100950-appF.
htm). Infection with mixed genotype 
3a + 3b was most prevalent (43.79%). 
Age distribution of patients with mixed 
genotype infections is shown in the 
Table. Approximately 33% of patients 
with mixed genotype infections were 
31–40 years of age and 22.5% were 
41–50 years of age.
Patterns of HCV mixed genotype 
infections in Pakistan are similar to 
those reported from India and Iran 
(8). However, the prevalence of HCV 
mixed genotype infections was lower 
(2%) (8) for Iran than for Pakistan. This 
lower rate may have been caused by 
use of a genotyping kit that can detect 
only genotypes 1a, 1b, 2, and 3a. Thus, 
mixed infections with other genotypes 
would not have been detected. A recent 
study in Brazil reported that mixed 
genotype infections were detected in 
3.9% of intravenous drug users and 
7.1% of former injecting drug users 
(9). These rates were similar to those 
in our study. In contrast, data from 
Sweden and Russia showed no mixed 
genotype infections in serum samples 
of chronically infected intravenous 
drug users, hemodialysis patients, and 
patients with hemophilia (10).
Women (288/7,390, 3.89%) 
in Pakistan had signifi cantly fewer 
HCV mixed genotype infections than 
men (719/10,791, 6.66%) (p<0.01). 
This fi nding might be the result of 
women having fewer risk factors for 
contracting mixed genotype infections. 
Possible risk factors for infection with 
mixed genotype infections analyzed 
were blood transfusions and use of 
blood products (51.3%); multiple use 
of needles or syringes (18.4%); sharing 
razors during shaving or circumcision, 
piercing instruments, nail clippers, 
and toothbrushes (13.7%); and major 
or minor dental surgery (9.5%). Mode 
of transmission was not clear for 7.1% 
of the patients.
In conclusion, the prevalence 
of HCV mixed genotype infections 
in Pakistan is higher than previously 
reported and higher among men 
(p<0.01). Comprehensive and detailed 
investigations are warranted to 
evaluate the clinical role of chronic 
HCV mixed genotype  infections, 
provide essential information that can 
be used to determine type and duration 
of therapy needed, and predict disease 
outcome.
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Patient age, y Total no. 
infections 0–10 11–20 21–30 31–40 41–50 51–60 >60 Unknown 
1 1a + 1b 0 0 2 5 6 7 0 1 21
1 + 2 1a + 2a 0 0 2 1 2 0 0 0 5
1b + 2a 0 0 0 1 2 1 0 1 5
1b + 2b 0 0 1 0 0 0 0 0 1
1 + 3 1a + 3b 0 3 4 4 3 1 0 0 15
1a + 3a 0 4 29 51 26 16 2 17 145
1c + 3a 0 1 2 2 1 0 0 1 7
1b + 3b 0 2 3 2 1 0 0 0 8
1b + 3a 0 7 45 90 79 32 3 31 287
1 + 4 1a + 4 0 0 0 0 3 1 0 1 5
2 + 3 2a + 3a 0 2 5 9 4 3 0 1 24
2a + 3b 0 1 5 8 5 3 0 1 23
3a + 2b 0 0 1 2 2 0 0 1 6
3 3a + 3b 1 15 94 142 87 46 13 43 441
3 + 4 3b + 4 0 1 0 2 2 1 0 0 6
3a + 4 0 0 0 2 4 0 0 0 6
3 + 6 3a + 6a 0 0 0 1 0 1 0 0 2
Total 1 36 193 322 227 112 18 98 1,007 
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West Nile Virus 
Aseptic Meningitis 
and Stuttering in 
Woman 
To the Editor: West Nile virus 
(WNV), a mosquito-borne fl avivirus, is 
closely related to St. Louis encephalitis 
virus and Japanese encephalitis virus 
(JEV). Most cases of WNV have been 
mild, but neuroinvasive disease has 
been observed, especially among older 
persons and immunocompromised 
persons (1,2). The most common 
neurologic manifestations of 
WNV are aseptic meningitis, 
meningoencephalitis, and encephalitis 
with or without acute fl accid paralysis 
(3). Other less common neurologic 
manifestations include Guillain-Barré 
syndrome, chorioretinitis, stroke-like 
symptoms, and unilateral brachial 
plexopathy (4,5).
We report a case of WNV 
aseptic meningitis in a 39-year-old 
immunocompetent woman who 
had severe headache with new-
onset stuttering. Her medical history 
included lumbar disc herniation and 
migraines, for which she was taking 
sumatriptan. Her symptoms started 
≈2 weeks before hospitalization 
and included a severe generalized 
headache initially thought to be a 
migraine, but sumatriptan resulted in 
no improvement. A few days later, 
she had fever and was intermittently 
stuttering. She denied recent travel 
or animal exposure but admitted to 
having received multiple mosquito 
bites during the preceding weeks.
At admission, she had a 
temperature of 101.3°F, pulse rate 
of 92 beats/min, blood pressure of 
130/80 mm Hg, and respiratory rate of 
16 breaths/min. She appeared mildly 
ill but was alert and oriented with no 
nuchal rigidity, photophobia, rash, or 
limb weakness. Results of a physical 
examination were unremarkable, and 
results of a neurologic examination 
were notable only for stuttering. 
Laboratory test results included a 
leukocyte count of 12,300 cells/mm3 
(63% neutrophils, 29% lymphocytes, 
7% monocytes, 1% basophils) and 
a platelet count of 204,000 cells/
mm3. Other laboratory values 
were unremarkable, and levels of 
serum transaminases and creatinine 
phosphokinase were within reference 
ranges. Cerebrospinal fl uid (CSF) was 
clear and contained 37 leukocytes/mm3 
(2% neutrophils, 78% lymphocytes, 
20% monocytes), 2 erythrocytes/mm3, 
a glucose level of 68 mg/dL, a protein 
level of 36 mg/dL, and a lactic acid 
level of 2.1 meq/L. No abnormalities 
were found on a cranial computed 
tomography scan.
The patient began treatment with 
acyclovir, 10 mg/kg intravenously, 
every 8 hours for 3 days. On hospital 
day 2, she underwent magnetic 
resonance imaging of the brain; 
results were within reference limits. 
On hospital day 3, her headache began 
to improve and she became afebrile, 
but she still stuttered occasionally. 
Results of CSF tests for enterovirus, 
herpes simplex viruses 1 and 2, and 
varicella zoster virus and PCR for 
human herpesvirus 6 were negative, 
and acyclovir was discontinued. On 
hospital day 5, she was discharged. 
Three days later, serum and CSF 
ELISA results for WNV were positive. 
A WNV ELISA was performed at 
ViroMed Laboratories (Minnetonka, 
MN, USA) by using a Focus Test Kit 
(Focus Diagnostics, Cypress, CA, 
USA), and the result was positive. The 
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